| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |